Pear Therapeutics Ch. 11 Liquidation Plan Confirmed

By Ben Zigterman · May 7, 2024, 8:48 PM EDT

A Delaware bankruptcy judge said at a hearing Tuesday that he would confirm the Chapter 11 liquidation plan for software-based medicine venture Pear Therapeutics after it sold most of its assets...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Case Information

Case Title

Pear Therapeutics (US), Inc.

Case Number

Court

Delaware

Nature of Suit

Date Filed

April 07, 2023

Recent Articles By Ben

April 10, 2024
Bankrupt Breast Implant Co. Gets OK For $50.5M Asset Sales
April 04, 2024
Acorda Gets Interim OK For $60M DIP With $40M Rollup
April 01, 2024
Pharma Co. Impel's Ch. 11 Liquidation Plan Approved
March 27, 2024
US Trustee Opposes New Official Committee In Talc Ch. 11
February 05, 2024
Zymergen Ch. 11 Plan Confirmed After Investor Objection
February 01, 2024
Bankrupt Pharma Co. Impel Gets OK For $17.5M Sale
January 29, 2024
US Trustee, Rite Aid Negotiate Revised Mediation Order
January 25, 2024
Eye Care Tech Co. Gets Tentative OK For $8M DIP
January 23, 2024
Ex-CEO's Counterclaims Not Allowed, Insys Trustee Says
January 19, 2024
McKesson Can't End A&P Creditors' $67M Clawback Suit